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PURPOSE. The Rs1h knockout mouse displays retinal features
typical for X-linked juvenile retinoschisis (RS). Consequently,
this mouse line represents an excellent model to study early
molecular events in RS.
METHODS. Whole genome expression profiling using DNA-mi-
croarrays was performed on total RNA extracts from retino-
schisin-deficient and wild-type murine retinas from postnatal
days 7, 9, 11, and 14. Quantitative real-time RT-PCR (qRT-PCR)
analysis of additional time points facilitated the refinement of
the temporal expression profile of differentially regulated tran-
scripts. Differential protein expression was confirmed by West-
ern blot analysis.
RESULTS. Based on biostatistic and knowledge-based DNA-mi-
croarray analyses we have identified differentially regulated
retinal genes in early postnatal stages of the Rs1h-deficient
mouse defining key molecular pathways including adhesion,
cytoskeleton, vesicular trafficking, and immune response. A
significant upregulation of Egr1 at P11 and several microglia/
glia-related transcripts starting at P11 with a peak at P14 were
identified in the diseased retina. The results provided evidence
that macrophage/microglia activation precedes apoptotic pho-
toreceptor cell death. Finally, the role of Egr1 in the pathogen-
esis of Rs1h-deficiency was investigated, and the results indi-
cated that activation of the MAPK Erk1/2 pathway occurs as
early as P7. Analyses of Rs1h/Y/Egr1/ double-knockout
mice suggest that Egr1 upregulation is not a prerequisite for
macrophage/microglia activation or apoptosis.
CONCLUSIONS. The findings imply that microglia/glia activation
may be triggering events in the photoreceptor degeneration of
retinoschisin-deficient mice. Furthermore, the data point to a
role of Erk1/2-Egr1 pathway activation in RS pathogenesis.
(Invest Ophthalmol Vis Sci. 2007;48:891–900) DOI:10.1167/
iovs.06-0641
Retinoschisis (RS) is a recessively inherited retinal dystrophywith macular disease often resulting in early-onset vision
loss. A hallmark of the disease is a limited splitting of the
central retina typically presenting as a spoke-wheel pattern.1
Peripheral schisis is seen in approximately 50% of affected
males and is usually located in the inferior temporal quadrant.
RS is caused by loss-of-function mutations in the RS1 gene on
Xp22.13.2 It encodes a 24-kDa protein, termed retinoschisin,
which is mainly secreted from photoreceptors as a homo-
oligomeric complex.3–7 Retinoschisin is almost entirely com-
posed of a highly conserved discoidin domain frequently found
in a wide range of membrane and extracellular proteins and
most likely mediating cell adhesion and cellular signaling pro-
cesses.8,9
To study retinoschisin function, we have generated a gene-
targeted mouse line with a disruption of Rs1h, the murine
orthologue of the human RS1 gene.10 The knockout mouse
appears to be an excellent disease model that closely resembles
human disease. For example, hemizygous male mice reveal a
characteristic “negative electroretinogram” and a highly disor-
ganized retinal architecture with schisis cavities within the
inner nuclear layer. This is accompanied by progressive loss of
cone and rod photoreceptor cells.10 Recently, we have shown
that the photoreceptor degeneration is due to apoptosis, more
specifically to the receptor mediated extrinsic pathway, with a
major burst of dying cells around postnatal day 18.11
To elucidate the molecular events that precede photorecep-
tor disease in the Rs1h knockout mouse, we applied DNA-
microarray-based mRNA profiling in retinal tissue of postnatal
stages (P)7, 9, 11, and 14. Besides Rs1h, we identified several
differentially expressed transcripts with a functional annota-
tion to adhesion, cytoskeleton, vesicular trafficking, and im-
mune response. Most of the genes in these groups are regu-
lated before the onset of an appreciable expression of genes
involved in apoptosis. Notably, many genes are implicated in
microglia/glia activity and inflammatory processes. An upregu-
lated expression of the early growth response gene 1 (Egr1)
was found relatively early in the disease process at P9. This has
further prompted us to investigate the role of Egr1 in RS




Animals were maintained in an air-conditioned environment on a
12-hour light–dark schedule at 20°C to 22°C, and had free access to
food and water. The health of the animals was regularly monitored, and
all procedures strictly adhered to the ARVO Statement for the Use of
Animals in Ophthalmic and Vision Research. The Egr1/ mouse was
purchased from Taconic (Ry, Denmark) and the Rs1h/Y mouse has
been described previously.10 These mice were on a C57BL/6 back-
ground and backcrossed for 12 generations.
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TABLE 1. List of Genes Analyzed by DNA-Microarrays and qRT-PCR Analysis in Mutant (Rs1h/Y) Versus Wild-Type Retinal Extracts
Age Unigene ID
Gene




Mm.38049 Tlr4 Toll-like receptor 4 Immune response 4.0
Mm.17484 Snca Synuclein, alpha Synaptic vesicle protein 4.0nc
Mm.3959 Nell2 Nel-like 2 homolog (chicken) Adhesion 2.3
Mm.66264 Stx6 Syntaxin 6 Vesicular traffic 2.2
Mm.333349 Wnk1 WNK lysine deficient protein kinase 1 Signaling 1.9
Mm.235863 Rcvrn Recoverin Photoreceptor protein 1.8
Mm.35650 Tspan31 Tetraspanin 31 Unknown 1.8
Mm.201322 Adnp Activity-dependent neuroprotective protein Neuroprotection 1.8
Mm.2020 Csrp2 Cysteine and glycine-rich protein 2 Proliferation/differentiation 1.8
Mm.233799 Igfbp4 Insulin-like growth factor binding protein 4 Proliferation/differentiation 1.8
Mm.207367 Zdhhc9 Zinc finger, DHHC domain containing 9 Signaling 1.8
Mm.1574 Wasl Wiskott-Aldrich syndrome-like (human) Cytoskeleton 1.8
Downregulated
Mm.12145 Rbbp4 Retinoblastoma binding protein 4 Nuclear protein 1.9
Mm.3781 Piga Phosphatidylinositol glycan, class A Adhesion 2.0
Mm.4559 Ggt1 Gamma-glutamyltransferase 1 Glutatione metabolism 2.4
Mm.332849 Wasf3 WAS protein family, member 3 Cytoskeleton 2.5
Mm.41982 Rs1h Retinoschisis 1 homolog (human) Adhesion 3.8c
P9* Upregulated
Mm.92529 Ubqln2 Ubiquilin 2 Ubiquitin metabolism 2.0
Downregulated
Mm.34405 Casp3 Caspase 3 Apoptosis 1.8
Mm.103669 Cabp5 Calcium binding protein 5 Calcium binding 1.9
Mm.5061 Arf2 ADP-ribosylation factor 2 Vesicular traffic 2.1
Mm.256034 Cct3 Chaperonin subunit 3 (gamma) Chaperon 2.1
Mm.378902 Cttn Cortactin Cytoskeleton 2.1
Mm.278357 Kns2 Kinesin 2 Cytoskeleton 2.2
Mm.3527 Ccng2 Cyclin G2 Cell cycle 2.2
Mm.41642 Rgs4 Regulator of G-protein signaling 4 Signaling 2.3
Mm.379376 Syt11 Synaptotagmin XI Synaptic vesicle protein 2.3
Mm.295284 Stom Stomatin Cytoskeleton 2.3
Mm.278865 Stxbp1 Syntaxin binding protein 1 vesicular traffic 2.3
Mm.2154 Mxi1 Max interacting protein 1 Transcription factor 2.5
Mm.3608 Pax6 Paired box gene 6 Transcription factor 2.6
Mm.21281 Rnf4 Ring finger protein 4 Transcription factor 2.7
Mm.143603 Sh3gl2 SH3-domain GRB2-like 2 Vesicular traffic 2.7
Mm.3193 Pkia Protein kinase inhibitor, alpha Signaling 2.7
Mm.308180 Ptplad1 Protein tyrosine phosphatase-like A domain containing 1 Signaling 2.7
Mm.43871 Trim35 Tripartite motif-containing 35 Apoptosis 2.8
Mm.4173 Mtap1b Microtubule-associated protein 1 B Cytoskeleton 2.8
Mm.218820 Dnm1l Dynamin 1-like Cytoskeleton 3.0
Mm.291928 Ctnnb1 Catenin (cadherin associated protein), beta 1, 88kDa Cytoskeleton 3.3
Mm.41982 Rs1h Retinoschisis 1 homolog (human) Adhesion 4.1c
Mm.279256 Ndrg3 N-myc downstream regulated gene 3 Proliferation/differentiation 4.2
P11* Upregulated
Mm.25168 Crip3 Cysteine-rich protein 3 Immune response 3.7
Mm.92529 Ubqln2 Ubiquilin 2 Ubiquitin metabolism 2.2
Mm.38049 Tlr4 Toll-like receptor 4 Immune response 2.2
Mm.181959 Egr1 Early growth response 1 Transcription factor 2.0c
Mm.234266 Sdc2 Syndecan 2 Vesicular traffic 1.9
Mm.362054 Pigq Phosphatidylinositol glycan, class Q Adhesion 1.8
Downregulated
Mm.263396 Itgb1 Integrin beta 1 (fibronectin receptor beta) Adhesion 1.8
Mm.5028 Inppl1 Inositol polyphosphate phosphatase-like 1 Immune response 1.8
Mm.256034 Cct3 Chaperonin subunit 3 (gamma) Chaperon 1.8
Mm.4950 Glp2 Interferon, alpha-inducible protein Immune response 1.9
Mm.253090 Ap2a2 Adaptor protein complex AP-2, alpha 2 subunit Vesicular traffic 1.9
Mm.24724 Ppp1r3c Protein phosphatase 1, regulatory (inhibitor) subunit 3C Glycogen metabolism 1.9
Mm.294821 0610042115 RIKEN cDNA 0610042115 gene Unknown 1.9
Mm.30837 Ndrg1 N-myc downstream regulated gene 1 Differentiation 1.9
Mm.1635 Pias3 Protein inhibitor of activated STAT 3 Immune response 1.9
Mm.38993 Clstn1 Calsyntenin 1 Vesicular traffic 2.0
Mm.1682 Ptpns1 Protein tyrosine phosphatase, non-receptor type
substrate 1
Adhesion 2.0
Mm.270484 Mkrn1 Makorin, ring finger protein, 1 Ubiquitin metabolism 2.0
Mm.295284 Stom Stomatin Cytoskeleton 2.0
Mm.347910 Ing4 Inhibitor of growth family, member 4 Cell cycle 2.0
Mm.5061 Arf2 ADP-ribosylation factor 2 Vesicular traffic 2.1
(continues)
892 Gehrig et al. IOVS, February 2007, Vol. 48, No. 2
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/932945/ on 07/05/2017
RNA Isolation
Retinal tissue was isolated from eye bulbs and purified under the
microscope from contaminating vitreous body and retinal pigment
epithelium/choriocapillaris. Total RNA was extracted (RNeasy Mini
Kit; Qiagen, Hilden, Germany).
Microarray Analysis and Statistical
Data Evaluation
Generation of double-stranded cDNA, preparation and labeling of cRNA,
hybridization to 430A 2.0 or 430 2.0 mouse genome arrays (Affymetrix,
Santa Clara, CA), washing, and scanning were performed according to the
protocol. Scanned images were analyzed (Microarray Suite version 5.0;
Affymetrix), to generate report files for quality control. For data analysis,
expression levels of single probes derived from Affymetrix CEL-files were
evaluated (ChipInspector software; Genomatix GmbH, Munich, Ger-
many). Previous annotations of the single oligonucleotide probes by Af-
fymetrix were disregarded, together with the grouping of the probes in
probe sets. The sequence of each single probe was mapped against the
current genome annotation (Build 36; National Center for Biotechnology
Information [NCBI], Bethesda, MD) and only probes with uniqueness in
the genome were used for analysis. Furthermore, single nucleotide poly-
morphisms were accounted for. Thereafter, ratios of single probe signals
were calculated and logarithmic transformation was performed. For nor-
malization, a linear total-intensity normalization algorithm was used. Sig-
nificantly regulated transcripts were discovered by a single sided permu-
tated t-test with a false discovery rate (FDR) calculation using the
significance analysis of microarray (SAM) algorithm.12 Scores were calcu-
TABLE 1 (continued). List of Genes Analyzed by DNA-Microarrays and qRT-PCR Analysis in Mutant (Rs1h/Y) Versus Wild-Type Retinal Extracts
Age Unigene ID
Gene
Symbol Gene Name Function
Array
FC
Mm.332967 Ube2h Ubiquitin-conjugating enzyme E2H Ubiquitin metabolism 2.1
Mm.3781 Piga Phosphatidylinositol glycan, class A Adhesion 2.1
Mm.291928 Ctnnb1 Catenin (cadherin associated protein), beta 1, 88kDa Cytoskeleton 2.2
Mm.143603 Sh3gl2 SH3-domain GRB2-like 2 Vesicular traffic 2.3
Mm.295246 4632413K17 RIKEN cDNA 4632413K17 gene Unknown 3.0
Mm.41982 Rs1h Retinoschisis 1 homolog (human) Adhesion 4.0c
P14† Upregulated
Mm.288474 Spp1 Secreted phosphoprotein 1 Immune response 4.3c
Mm.182785 Emp1 Epithelial membrane protein 1 Adhesion 2.5
Mm.100144 S100a6 S100 calcium binding protein A6 (calcyclin) Calcium binding 2.4c
Mm.46301 Tyrobp TYRO protein tyrosine kinase binding protein Immune response 2.3c
Mm.38498 Krt1-15 Keratin complex 1, acidic, gene 15 Cytoskeleton 2.3
Mm.383993 Krt2-5 Keratin complex 2, basic, gene 5 Cytoskeleton 2.2
Mm.239516 Clec7a C-type lectin domain family 7, member a Macrophage protein 2.2c
Mm.175661 Ifitm1 Interferon induced transmembrane protein 1 Immune response 2.2
Mm.378931 Gsto1 Glutathione S-transferase omega 1 Detoxification 2.1
Mm.15819 Cd68 CD68 antigen Macrophage protein 2.1c
Mm.3999 Mpeg1 Macrophage expressed gene 1 Macrophage protein 2.1c
Mm.347407 Cebpd CCAAT/enhancer binding protein (C/EBP), delta Transcription factor 2.1
Mm.2409 Adh1 Alcohol dehydrogenase 1 (class 1) Detoxification 2.0
Mm.1282 Ccl3 Chemokine (C-C motif) ligand 3 Immune response 2.0
Mm.45436 Lyzs Lysozyme Immune response 2.0c
Mm.355327 Dsp Desmoplakin Cytoskeleton 2.0
Mm.4646 Krt1-13 Keratin complex 1, acidic, gene 13 Cytoskeleton 2.0
Mm.22673 Fcer1g Fc receptor, IgE, high affinity 1, gamma polypeptide Macrophage protein 1.9c
Mm.1239 Gfap Glial fibrillary acidic protein Cytoskeleton 1.9c
Mm.248615 Lgals3 Lectin, galactose binding, soluble 3 Adhesion 1.9
Mm.303231 Cxcl12 Chemokine (C-X-C motif) ligand 12 Immune response 1.9
Mm.45173 Msr2 Macrophage scavenger receptor 2 Macrophage protein 1.9c
Mm.275715 1700063D05 RIKEN cDNA 1700063D05 gene Unknown 1.9c
Mm.42230 Cyp26A1 Cytochrome P450, family 26, subfamily a, polypeptide 1 Retinoid metabolism 1.9c
Mm.22723 Gpr126 G protein-coupled receptor 126 Signaling 1.9nc
Mm.6974 Krt1-14 Keratin complex 1, acidic, gene 14 Cytoskeleton 1.9
Mm.268000 Vim Vimentin Cytoskeleton 1.8
Mm.244003 Scel Sciellin Epithelial barrier 1.8
Mm.137 Ccl6 Chemokine (C-C motif) ligand 6 Immune response 1.8c
Mm.271711 Tagln2 Transgelin 2 Cytoskeleton 1.8c
Mm.2570 C1qb Complement component 1q, beta polypeptide Immune response 1.8
Downregulated
Mm.336111 Syt1 Synaptotagmin 1 Synaptic vesicle protein 1.8
Mm.259879 Birc4 Baculoviral IAP repeat-containing 4 Apoptosis/antiApoptosis 1.8
Mm.272264 Stx3 Syntaxin 3 Vesicular traffic 1.8
Mm.218473 Serinc3 Srine incorporator 3 Apoptosis/antiApoptosis 1.8
Mm.296520 Vps35 Vacuolar protein sorting 35 Vesicular traffic 1.8
Mm.306026 Epb4.1l2 Erythrocyte protein band 4.1-like 2 Cytoskeleton 1.9
Mm.30837 Ndrg1 N-myc downstream regulated gene 1 Differentiation 1.9
Mm.279923 Nedd4 Neural developmentally downregulated gene 4 Ubiquitin metabolism 2.1
Mm.1228 Cryaa Crystallin, alpha A Eye lens protein 2.2
Mm.41982 Rs1h Retinoschisis 1 homologue (human) Adhesion 3.6c
c, confirmed; nc, not confirmed.
* Three Rs1h/Y and three wild-type retinal cRNA samples were hybridized to the Mouse Genome 430A 2.0 Array.
† Six Rs1h/Y and seven wild-type retinal cRNA samples were hybridized to the Mouse Genome 430 2.0 Array.
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lated for each gene based on the multiple of expression level changes
relative to the standard deviation of repeated measurements. To estimate
FDR, nonsense genes were identified by analyzing permutations of the
measurements. An FDR of 5% was chosen in the first step of our statistical
analysis and lists of genes that fulfill these criteria for data sets at P7, P9,
P11, and P14 are given in Supplementary Tables S1, S2, S3, and S4,
respectively (all Supplementary Tables are available online at http://www.
iovs.org/cgi/content/full/48/2/891/DC1). To increase stringency, a 1.8
fold-change and a minimum signal intensity of 50 were selected as inclu-
sion criteria (Table 1).13 Functional annotation of transcripts was per-
formed on computer (BiblioSphere, Pathway Edition; Genomatix, Mu-
nich, Germany).14 The microarray data set of this study is publicly
available at the NCBI Gene Expression Omnibus (http://www.ncbi.nlm.
nih.gov/geo/) through accession number GSE5581.
Quantitative Real-Time RT-PCR Analysis
Total RNAs from time points P5, P7, P9, P11, P13, P14, P15, P18, and
P22 from Rs1h/Y mice and RNAs from time points P18 and P24 from
Rs1h/Y/Egr1/ and Rs1h/Y/Egr1/ mice were used to generate
cDNA. For each condition two animals (four eyes) were analyzed in
triplicate measurements. First strand cDNA synthesis was performed
(Superscript II; Invitrogen, Karlsruhe, Germany). Quantitative real-time
RT-PCR (qRT-PCR) was performed with a thermocycler (iCycler; Bio-
Rad, Munich, Germany) as described previously,11 using primers listed
in Supplementary Table S5. Input cDNA quantities were estimated by
comparison to expression of five reference genes (Atp5b, Gusb, Hprt1,
Rpl4, and Sdha).15
SDS Gel Electrophoresis and Western
Blot Analysis
Retinal tissue was homogenized in buffer (PhosphoSafe; Novagen,
Madison, WI). Quantitation of protein extracts was performed by a
protein assay based on the Bradford method (Bio-Rad). Western blots
were prepared after SDS-PAGE of 20 g protein and labeled with
phospho-ERK 1/2 pAb (dilution 1:1.000; Sigma-Aldrich, Munich, Ger-
many), ERK 1/2 pAb (dilution 1:2.000; Sigma-Aldrich), or -actin mAb
(dilution 1:60.000; Sigma-Aldrich). After the blots were washed in
PBS/Tween-20, they were labeled with goat anti-rabbit and goat anti-
mouse Ig-peroxidase (dilution 1:10.000; Calbiochem, La Jolla, CA) for
detection by enhanced chemiluminescence (ECL).
Immunofluorescence Labeling and TUNEL-Assay
Immunofluorescence studies of retinal cryosections and TUNEL-stain-
ing of eye bulbs from Rs1h-deficient, Egr1-deficient (Taconic) or dou-
ble-knockout mice (Rs1h/Y/Egr1/ and Rs1h/Y/Egr1/) was per-
formed exactly as described recently.11
RESULTS
Microarray Analysis
To study molecular events accompanying retinoschisin defi-
ciency, we first analyzed gene expression in retinal tissues
from Rs1h-knockout and wild-type mice at P7, P9, and P11. In
wild-type animals, expression of Rs1h mRNA is detectable at
P5 and reaches adult levels at P11 (data not shown). Retinal
cRNAs from three Rs1h/Y mice and three wild-type litter-
mates at P7, P9, and P11 were hybridized to microarrays
(Mouse Genome 430A 2.0 GeneChips; Affymetrix) detecting
14,000 annotated mouse genes. For a second round analysis of
stage P14, cRNAs from six Rs1h-knockout mice and seven
wild-type littermates were hybridized to microarrays (Mouse
Genome 430 2.0 GeneChips; Affymetrix) covering more than
34,000 mouse genes.
Initial evaluation of single probe expression ratios with a
false discovery rate (FDR) of 5% based on SAM analysis indi-
cated differential expression of 55 genes on P7, 60 genes on
P9, 87 genes on P11, and 262 genes on P14 (for gene lists see
Supplementary Tables S1–S4). Based on own experience with
previous microarray studies,13 we next applied higher-strin-
gency conditions selecting for genes with at least 1.8-fold
expression changes and minimum signal intensities of 50 signal
units. Thereafter, the number of significantly regulated genes
was reduced to 17 for P7, 24 for P9, 27 for P11, and 41 for P14
(Table 1). The top regulated genes apart from Rs1h were Tlr4
(4.0-fold) and Wasf3 (2.5-fold) at P7, Ubqln2 (2.0-fold) and
Ndrg3 (4.2-fold) at P9, Crip3 (3.7-fold) and the unknown
gene 4632413K17 (3.0-fold) at P11, and Spp1 (4.3-fold) and
Cryaa (2.2-fold) at P14.
To characterize further the observed mRNA regulations,
molecular function annotation of pathways was performed. As
displayed in Figure 1, grouping of genes into pathways with at
least two entries recurring in the time course (colored seg-
ments) yielded the main categories cytoskeleton, adhesion,
vesicular trafficking, immune response, and apoptosis. At P7,
genes involved in adhesion and vesicular trafficking were
prominent, whereas at later stages immune response and mi-
croglia/glia-specific genes were mainly detected. Genes regu-
lated at several time points include the induced immune reg-
ulatory gene Tlr4 and the downregulated vesicular trafficking
gene Sh3gl2 (Table 2). All commonly regulated transcripts
were found at P11 and we therefore conclude that these
molecular events represent initial as well as secondary changes
related to Rs1h deficiency. The large number of upregulated
genes at P14 related to immune response also indicates a
significant involvement of microglia and glia cells in RS. Be-
cause transcription factors are of particular importance for
regulatory responses, the upregulation of Egr1 was verified by
qRT-PCR along with the immune response genes induced at
P14 (Table 1 and Fig. 1). Six transcripts which are increased at
P14, namely Spp1, Emp1, S100a6, Lgals3, Cxcl12, and Vim
contain verified Egr1 binding sites in their regulatory regions,
suggesting that early Egr1 expression could induce transcrip-
tional waves at later time points.
Refined Expression Profiling by qRT-PCR
and Immunohistochemistry
We next examined the upregulated transcripts at postnatal
stages P7, P9, P11, P13, P15, P18, and P22 by qRT-PCR (Fig. 2).
Egr1 was significantly induced in the retinoschisin-deficient
retina starting at P9 (P  0.05), further upregulated at P11 and
P13 (P 0.001 and P 0.05, respectively), unchanged at P15,
and again strongly induced at P18 and P22 (Fig. 2a). We then
quantified mRNA levels of 1700063D05, a gene with an as yet
unknown function (Fig. 2b). Upregulation of 1700063D05
transcripts started in Rs1h knockout mice at P13 but showed a
marked decline from P15 to P22. The expression profile 1 in
Figure 2c subsumes the mRNA pattern of 10 upregulated genes
identified in the DNA-microarray experiments at P14 including
Spp1, Tyrobp, Clec7a, Cd68, Ccl6, Fcer1g, Lyzs, Mpeg1, Msr2,
and Cd53 (Table 1 and Supplementary Table S4) comprising
microglia-associated genes. There is a steady increase in gene
expression starting between P11 and P13 with a maximum at
P18 and a decline beyond this time point. Expression profile 2
(Fig. 2d) represents the expression pattern of five genes in-
cluding S100a6, Cyp26a1, Tgm2, Tagln2, and Gfap revealing
a sharp upregulation between P15 and P18 and elevated levels
until P22.
We then sought to define precisely the chronological ex-
pression of microglia-associated genes exemplified by Cd68
and Clec7a in comparison with transcripts involved in the
extrinsic pathway of apoptosis (Casp8 and Tnfrsf6). There was
a steady increase of expression profile 1 transcripts beginning
at P13 while apoptosis-related upregulation started not until
894 Gehrig et al. IOVS, February 2007, Vol. 48, No. 2
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/932945/ on 07/05/2017
P16 (Fig. 3). These data clearly indicate that microglia-related
gene expression precedes expression of apoptosis-related tran-
scripts in the retinoschisin-deficient retina by several days.
To correlate mRNA profiles with protein expression, we
performed immunohistochemistry on Rs1h knockout and wild-
type retinal sections from three developmental stages (P14,
P18, and P24). Anti-F4/80 was used as a marker of microglia
activation, whereas the glial fibrillary acidic protein (Gfap)
served as a stress indicator of retinal Mu¨ller glial cells. At P14,
expression of Gfap (green) was similar in the retinoschisin-
deficient and the wild-type retina, whereas the activation
marker F4/80 (red) indicated isolated microglia in the inner
nuclear layer of the Rs1h/Y retina (Fig. 4, left). At P18 and P24
there was prominent labeling of the two marker proteins in the
Rs1h-knockout tissue (Fig. 4, middle and right) fully corrobo-
rating our qRT-PCR data (Figs. 2c, 2d, 3).
Analysis of the Erk1/2 Pathway in the
Retinoschisin-Deficient Retina
Our data demonstrate that upregulation of Egr1 at P9 may
contribute to the pathogenesis of the retinoschisin-deficient
FIGURE 1. Molecular function anno-
tation of significantly regulated genes
at time points P7 (a), P9 (b), P11 (c),
and P14 (d) in retinoschisin-deficient
versus wild-type retina. Colored seg-
ments: common pathways recurring
at different stages; gray segments:
unique at one time point. All genes
included in these pathways are listed
in Table 1.
TABLE 2. List of Commonly Regulated Genes at Different Stages in Mutant (Rs1h/Y) versus Wild-Type Retinal Extracts




Mm.38049 Tlr4 Toll-like receptor 4 2.2 P7, P11
Mm.92529 Ubqln2 Ubiquilin 2 2.2 P9, P11
Downregulated genes
Mm.256034 Cct3 Chaperonin subunit 3 (gamma) 1.8 P9, P11
Mm.30837 Ndrg1 N-myc downstream regulated gene 1 1.9 P11, P14
Mm.5061 Arf2 ADP-ribosylation factor 2 2.1 P9, P11
Mm.3781 Piga Phosphatidylinositol glycan. class A 2.1 P7, P11
Mm.291928 Ctnnb1 Catenin (cadherin associated protein), beta 1, 88kDa 2.2 P9, P11
Mm.295284 Stom Stomatin 2.3 P9, P11
Mm.143603 Sh3gl2 SH3-domain GRB2-like 2 2.3 P9, P11
Mm.41982 Rs1h Retinoschisis 1 homologue (human) 3.6 P7–P14
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retina. Egr1 expression is induced by external signals including
growth factors, hormones, neurotransmitters, or toxins via the
serine-threonine kinases Erk1 and Erk2 in the mitogen-acti-
vated protein kinase (MAPK) pathway.16,17 We therefore ana-
lyzed the phosphorylation status of Erk1/2 in the Rs1h-defi-
cient retina at stages P5, P7, P11, and P13 (Fig. 5). Western blot
analysis revealed a significant increase in Erk1/2 phosphoryla-
tion (p-Erk1/2) at P7, P11, and P13 but not at P5 in retinal
extracts from retinoschisin-deficient versus wild-type mice
(Fig. 5).
Characterization of the Rs1h/Y/Egr1/
Double-Knockout Mouse
To investigate the role of Egr1 in RS, we generated double-
knockout mice deficient for both retinoschisin and Egr1. His-
tologic examination of retinal sections from double knockout
mice at P18 and P24 showed pathologic manifestations typical
for the single Rs1h knockout.10 Furthermore, three knockout
genotypes (Rs1h/Y/Egr/, Rs1h/Y/Egr/, and Rs1h/Y/
Egr/) were analyzed at P18 and P24 for mRNA expression of
the upregulated marker genes 1700063D05, Cd68, and Gfap
(Figs. 6a–c). qRT-PCR demonstrates a significant increase of all
three transcripts in the Rs1h-deficient retina independent of
the Egr1 genotype (Egr1/ or Egr1/) similar to the data
obtained for the Rs1h single knockout. This suggests that
partial or full Egr1 deficiency does not prevent induction of
microglia/glia activation markers in the Rs1h/Y retina.
We finally explored possible effects of Egr1-deficiency on
the extrinsic apoptotic pathway and identified that the apopto-
sis markers Tnfrsf6 and Casp8 are upregulated in the retino-
schisin-deficient retina, independent of Egr1 expression status
(Egr1/ or Egr1/; Figs. 6d, 6e). To further corroborate
these findings, TUNEL assays were performed in retinal sec-
tions of the three genotypes Rs1h/Y/Egr/, Rs1h/Y/
Egr/, and Rs1h/Y/Egr/ at developmental stages P18 and
P24. The number of apoptotic nuclei was significantly in-
creased in Rs1h/Y versus wild-type retinas, either on the
Egr1/ or the Egr1/ background (Fig. 7). This suggests no
direct link between transcriptional Egr1 upregulation and ap-
optotic events in the retinoschisin-deficient mouse.
DISCUSSION
In the present study, we performed microarray analysis and
qRT-PCR in the Rs1h/Y retina compared with wild-type. At
P7, where Rs1h is normally present and where early events in
pathogenesis are expected, transcripts for adhesion molecules,
photoreceptor-specific proteins, cytoskeleton, and neuropro-
tective proteins were detected. Among these, Nell2 is a neu-
ron-specific secreted glycoprotein protecting against oxygen-
glucose-deprivation- and -amyloid-induced cell death,18
whereas overexpression of the photoreceptor protein recov-
FIGURE 2. Quantitative RT-PCR anal-
ysis of differentially regulated genes in
the retinoschisin-deficient (ko) versus
wild-type (wt) retina. (a) Developmen-
tal time course of expression for Egr1
and (b) for the hypothetical transcript
1700063D05, respectively. (c) Profile
1 depicts the expression pattern of 10
genes, including Ccl6, Cd53, Cd68,
Clecsf12, Fcer1g, Lyzs, Mpeg1, Msr2,
Spp1, and Tyrobp whereas (d) profile
2 comprises five genes, including
S100a6, Gfap, Cyp26a1, Tgm2, and
Tagln2. The y-axis depicts the relative
expression levels of the respective
genes either separately for Rs1h/Y
and wild-type (wt) or for both condi-
tions calculated by subtracting relative
expression values of wt from ko. Error
bars, SD. Statistical significance is
given as *P  0.05 or **P  0.001
(Student’s t-test). Experiments were
performed with retinas from two dif-
ferent animals (four eyes) and each
were performed in triplicate measure-
ments.
FIGURE 3. Quantitative real-time RT-PCR analysis of macrophage-
(Cd68 and Clec7a) and apoptosis-related (Tnfrsf6 and Casp8) tran-
scripts. The onset of differential expression in retinoschisin-deficient
(Rs1h/Y) versus wild-type (wt) is distinctly earlier for Cd68 and
Clec7a compared with Tnfrsf6 and Casp8.
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erin leads to photoreceptor degeneration.19 The strongest up-
regulated gene at P7, Tlr4, is expressed in retinal pigment
epithelium20 and in activated microglia.21 Furthermore, human
TLR4 genetic variants are associated with age-related macular
degeneration,22 suggesting functional consequences of these
aberrant transcript patterns.
We have identified 10 genes gradually increasing in expres-
sion starting at P11 (profile 1), a steep upregulation of
1700063D05 at P13, and induction of five genes in profile 2
(1700063D05, Cyp26a, S100a6, Tagln2, and Gfap) between
P15 and P18. Notably, P14 is a time point where first his-
topathological features such as cystlike structures in the inner
retina, disruption of the outer plexiform layer, and disorgani-
zation and displacement of retinal cells become apparent in
Rs1h/Y animals.10 Although 1700063D05 is of unknown
function, Cyp26a1 plays a role in retinoic acid metabolism,23
S100a6 is functionally involved in cell cycle progression,24,25
and Tagln2 represents a marker of smooth muscle differentia-
tion.26 Whereas a correlation between RS and upregulation of
transcripts 1700063D05, Cyp26a, S100a6, and Tagln2may be
challenging to reconcile, increased expression of the interme-
diate filament protein Gfap most likely represents a reactive
response of Mu¨ller glia cells and astrocytes to the degenerative
processes caused by the lack of retinoschisin. Accordingly,
consistent upregulation of Gfap in other models of retinal
injury has been reported, including glaucoma,27,28 retinal tear
injury,29 and diabetic retinopathy.30
The expression data at time points P11 and P14 clearly
implicate microglia-mediated processes in pathologic events of
retinoschisin deficiency. Several genes are related to immune
response and are expressed in microglia. Clec7a is a pattern-
recognition receptor detecting -glucans from fungi and
plants, resulting in inflammation31,32 and Fcer1g encodes the
gamma chain of the IgE receptor CD23, which is important for
allergic reactions.33 Lysz is an inducible marker of phagocyto-
sis expressed during microglia activation after neuronal
injury.34 The chemokine Ccl6 acts as mediator of astrocyte and
microglia migration in vitro,35 whereas the secreted phospho-
protein Spp1, participates in cellular attachment.36 Egr1 in-
duces the expression of inflammatory mediators such as TNF-
or macrophage inflammatory protein-2 (MIP-2).16,37,38 Egr1,
together with Tyrobp, also controls terminal differentiation
and activation of macrophages.39–42
Several of these immune-regulatory genes (e.g., Spp1, Lysz,
and C1qb) and the immediate early response gene Egr1 have
also been associated with retinal disease in DNA-microarray
approaches similar to those used in our study, such as analyses
of ischemic injury and light-induced damage to the retina.43–45
Egr1, which is upregulated at P9 is involved in a large number
of cellular events ranging from mitogenesis, differentiation, cell
protection and survival, pro- and antiapoptotic processes to
macrophage differentiation.40,46 Although not unique to reti-
noschisin-deficiency, this suggests that Egr1 may act as a con-
vergence point for multiple signaling cascades, which is also
supported by our finding that the promoters of six commonly
induced genes at P14 related to adhesion, immune response,
FIGURE 4. Immunofluorescence mi-
croscopy on cryosections of Rs1h/Y
and wild-type mouse retinas at P14,
P18, and P24. Macrophages-micro-
glia were stained with the specific
marker F4/80 (red), showing initial
macrophage activation at P14 and
more prominent labeling at postnatal
day P18 and P24 in the Rs1h/Y ret-
ina. Mu¨ller glial cells are stained with
the GFAP antibody (green). Retinal
sections of Rs1h knockout retina re-
veal cellular disorganization and
small cavities starting at P14. Retinal
layers are shown in the wild-type P14
image: outer nuclear layer (ONL),
outer plexiform layer (OPL), inner
nuclear layer (INL), inner plexiform
layer (IPL), and ganglion cell layer
(GCL).
FIGURE 5. Western blot analysis of phosphorylated Erk1/2 (pErk1/2)
and nonphosphorylated Erk1/2 (Erk1/2) performed on retinal protein
extracts from single Rs1h-deficient (Rs1h/Y) and wild-type (wt) mice
at P5, P7, P11, and P13. In comparison to the wild-type extracts,
increased expression levels of pErk1/2 are apparent at P7 and P11 in
the retinoschisin-deficient samples. The blot was reprobed with an
anti--actin (Actb) antibody as a loading control.
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and cytoskeleton contain verified Egr1-binding sites. It is there-
fore of great interest to identify further the events upstream
and downstream of the initiation of Egr1 transcription. Toward
this end, we analyzed the phosphorylation of the MAP Erk1/2
kinases and have found that this pathway was activated in the
retinoschisin-deficient retina as early as P7. In mammalian cells,
the MEK1/2/ERK signaling pathway plays a crucial role in
immediate early gene (IEG) induction by directly activating IEG
promoter-bound transcription factors such as Egr1.47 Further
studies are needed to determine Egr1-expressing cell types in
the diseased retina and to analyze the gene activation cascade
upstream of Egr1. So far, the mechanism coupling the extra-
cellular membrane–associated retinoschisin to intracellular sig-
naling remains elusive, but it may be relayed via an as yet
unknown membrane receptor protein.
We were also interested in exploring downstream conse-
quences of Egr1 activation. However, double-knockout mice
deficient of both Rs1h and Egr1 were indistinguishable from
Rs1h single-knockout mice, specifically with regard to retinal
histology and expression profiles of microglia/glia- and apop-
tosis-related transcripts. Our experiments are in line with find-
ings demonstrating that Egr1/mice have no obvious defects
in macrophage differentiation.48,49 However, data from an an-
tisense strategy demonstrate that Egr1 is essential for cell
growth and macrophage differentiation.40,50,51 These contro-
versial results may be explained by functional redundancy of
remaining family members Egr2, Egr3, and Egr4 which are
often coordinately regulated.52 To further unravel the role of
Egr1 in retinoschisin-deficiency, it may therefore be necessary
to simultaneously target several Egr genes.
Commonly, programmed cell death is thought to activate
microglia cells resulting in the clearance of dying cells,53 al-
though in some cases macrophage stimulation conversely has
been demonstrated to trigger apoptosis.54–56 We recently re-
ported that postnatal photoreceptor cell death in the Rs1h/Y
knockout mouse is due to extrinsic apoptosis at P18.11 We
FIGURE 6. Quantitative real-time RT-
PCR analysis of 1700063D05, Cd68,
and Gfap as well as genes involved in
the extrinsic pathway of apoptosis
(Tnfrsf6 and Casp8) in retinal ex-
tracts from three mouse genotypes
Rs1h/Y/Egr1/, Rs1h/Y/Egr1/,
and Rs1h/Y/Egr1/. The analysis
was done for two stages at P18 and
P24, respectively. Expression of succi-
nate dehydrogenase subunit A (Sdha)
serves as control for cDNA integrity.
Experiments were performed with ret-
inas from two different animals (four
eyes) and were performed in triplicate
measurements.
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have now defined the relative time course of microglia- and
apoptosis-related events in this model and show that the two
events can be unambiguously separated. Whereas immune-
related genes are upregulated starting as early as P11, apopto-
sis-associated transcripts are increased in the Rs1h-deficient
retina only after P16. We therefore conclude that microglia
activation precedes the onset of apoptotic cell death and may
even be involved in triggering apoptosis in the diseased retina.
The goal of the study was to analyze molecular events
caused by retinoschisin-deficiency in a mouse model for RS.
Our findings indicate activation of the Erk1/2 pathway at P7
followed by an upregulation of transcription factor Egr1 at P9.
Functional clustering highlights key pathways including adhe-
sion, cytoskeleton, vesicular trafficking and glia-cell related
immune responses. As apoptosis-related gene expression in the
retinoschisin-deficient retina is not initiated before P16, we
hypothesize that microglia/glia-mediated processes precede
and may even cause events of programmed photoreceptor cell
death.
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